《Journal Of Clinical Pharmacology》雜志的最新年發(fā)文量為165篇。
這表明該刊在每年都會精選并發(fā)表一定數(shù)量的高質(zhì)量文章，以保持其在藥學(xué)領(lǐng)域的學(xué)術(shù)影響力。
該刊聚焦于醫(yī)學(xué)-藥學(xué)領(lǐng)域的前沿研究，致力于推動該領(lǐng)域新技術(shù)和新知識的傳播與應(yīng)用。同時它積極鼓勵研究人員詳細發(fā)表其高質(zhì)量的實驗研究和理論成果。
該刊的平均審稿周期約為 。
Journal Of Clinical Pharmacology 雜志發(fā)文統(tǒng)計
文章名稱引用次數(shù)
- A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential34
- Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress20
- Developmental Changes in Pharmacokinetics and Pharmacodynamics20
- A Phase Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment18
- Pharmacokinetics, Safety, and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment15
- Population Pharmacokinetics of Tacrolimus in Transplant Recipients: What Did We Learn About Sources of Interindividual Variabilities?12
- Clinical Pharmacology of the Reversible and Potent P2Y(12) Receptor Antagonist ACT-246475 After Single Subcutaneous Administration in Healthy Male Subjects12
- Population PK Analyses of Ubrogepant (MK-1602), a CGRP Receptor Antagonist: Enriching In-Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling12
- The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF-06700841) in Healthy Subjects and Patients With Plaque Psoriasis12
- Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System12
國家/地區(qū)發(fā)文量
- USA409
- GERMANY (FED REP GER)50
- England47
- Japan43
- Switzerland38
- CHINA MAINLAND35
- Netherlands30
- Canada25
- France21
- Italy19
